| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Amir Hossein Mirhashemi, Mohammad Sadegh Ahmad Akhoundi, Sedigheh Sheikhzadeh, Nafiseh Momeni, Ahmadreza Dehpour, Mojgan Alaeddini, Yasaman Kheirandish, Homa Farhadifard, Elahe Ansar. Effect of Fluoxetine Consumption on Orthodontic Tooth Movement in Rats. Journal of dentistry (Tehran, Iran). vol 12. issue 12. 2016-08-25. PMID:27559347. |
fluoxetine is a selective serotonin re-uptake inhibitor (ssri) widely used for depression, bipolar disorder, anxiety and obsessive-compulsive disorder. |
2016-08-25 |
2023-08-13 |
rat |
| Mats B Humble, Susanne Bejero. Orgasm, Serotonin Reuptake Inhibition, and Plasma Oxytocin in Obsessive-Compulsive Disorder. Gleaning From a Distant Randomized Clinical Trial. Sexual medicine. vol 4. issue 3. 2016-08-23. PMID:27320409. |
orgasm, serotonin reuptake inhibition, and plasma oxytocin in obsessive-compulsive disorder. |
2016-08-23 |
2023-08-13 |
Not clear |
| Mats B Humble, Susanne Bejero. Orgasm, Serotonin Reuptake Inhibition, and Plasma Oxytocin in Obsessive-Compulsive Disorder. Gleaning From a Distant Randomized Clinical Trial. Sexual medicine. vol 4. issue 3. 2016-08-23. PMID:27320409. |
serotonin reuptake inhibitors (sris) are widely used for the treatment of psychiatric disorders, including obsessive-compulsive disorder (ocd). |
2016-08-23 |
2023-08-13 |
Not clear |
| Yunhui Chen, Michal Juhas, Andrew J Greenshaw, Qiang Hu, Xin Meng, Hongsheng Cui, Yongzhuo Ding, Lu Kang, Yubo Zhang, Yuhua Wang, Guangcheng Cui, Ping L. Data on the impact of SSRIs and depression symptoms on the neural activities in obsessive-compulsive disorder at rest. Data in brief. vol 8. 2016-08-09. PMID:27504477. |
this article also provides supplementary information to our research article, i.e., between - group comparisons of the effect of selective serotonin reuptake inhibitors (ssris) and combined depression symptoms on resting-state neural activities in obsessive-compulsive disorder. |
2016-08-09 |
2023-08-13 |
Not clear |
| Mohammadrasoul Khalkhali, Setareh Aram, Homa Zarrabi, Moosa Kafie, Abtin Heidarzade. Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial. Iranian journal of psychiatry. vol 11. issue 2. 2016-07-20. PMID:27437007. |
lamotrigine augmentation versus placebo in serotonin reuptake inhibitors-resistant obsessive-compulsive disorder: a randomized controlled trial. |
2016-07-20 |
2023-08-13 |
Not clear |
| Mohammadrasoul Khalkhali, Setareh Aram, Homa Zarrabi, Moosa Kafie, Abtin Heidarzade. Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial. Iranian journal of psychiatry. vol 11. issue 2. 2016-07-20. PMID:27437007. |
serotonin reuptake inhibitors are frequently used in first-line treatments for patients with obsessive-compulsive disorder. |
2016-07-20 |
2023-08-13 |
Not clear |
| Mohammadrasoul Khalkhali, Setareh Aram, Homa Zarrabi, Moosa Kafie, Abtin Heidarzade. Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial. Iranian journal of psychiatry. vol 11. issue 2. 2016-07-20. PMID:27437007. |
this study was designed to evaluate the possible efficacy of lamotrigine, a glutamatergic agent in serotonin reuptake inhibitors-resistant patients with obsessive-compulsive disorder. |
2016-07-20 |
2023-08-13 |
Not clear |
| Eyup Sabri Ercan, Ulku Akyol Ardic, Elif Ercan, Deniz Yuce, Sibel Dura. A Promising Preliminary Study of Aripiprazole for Treatment-Resistant Childhood Obsessive-Compulsive Disorder. Journal of child and adolescent psychopharmacology. vol 25. issue 7. 2016-06-14. PMID:26375768. |
obsessive-compulsive disorder (ocd) is a relatively frequent disease in childhood, which is generally treated with selective serotonin reuptake inhibitors (ssris) and/or clomipramine and cognitive behavioral therapy (cbt). |
2016-06-14 |
2023-08-13 |
Not clear |
| Markus Dold, Martin Aigner, Rupert Lanzenberger, Siegfried Kaspe. Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials. The international journal of neuropsychopharmacology. vol 18. issue 9. 2016-05-26. PMID:25939614. |
antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: an update meta-analysis of double-blind, randomized, placebo-controlled trials. |
2016-05-26 |
2023-08-13 |
Not clear |
| Markus Dold, Martin Aigner, Rupert Lanzenberger, Siegfried Kaspe. Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials. The international journal of neuropsychopharmacology. vol 18. issue 9. 2016-05-26. PMID:25939614. |
many patients with obsessive-compulsive disorder do not respond adequately to serotonin reuptake inhibitors. |
2016-05-26 |
2023-08-13 |
Not clear |
| Michael G Wheaton, David Rosenfield, Edna B Foa, H Blair Simpso. Augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: What moderates improvement? Journal of consulting and clinical psychology. vol 83. issue 5. 2016-05-23. PMID:26009783. |
augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: what moderates improvement? |
2016-05-23 |
2023-08-13 |
Not clear |
| Michael G Wheaton, David Rosenfield, Edna B Foa, H Blair Simpso. Augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: What moderates improvement? Journal of consulting and clinical psychology. vol 83. issue 5. 2016-05-23. PMID:26009783. |
patients with obsessive-compulsive disorder (ocd) often only partially respond to serotonin reuptake inhibitors (sris). |
2016-05-23 |
2023-08-13 |
Not clear |
| Carmen P McLean, Laurie J Zandberg, Page E Van Meter, Joseph K Carpenter, Helen Blair Simpson, Edna B Fo. Exposure and response prevention helps adults with obsessive-compulsive disorder who do not respond to pharmacological augmentation strategies. The Journal of clinical psychiatry. vol 76. issue 12. 2016-05-06. PMID:26613263. |
serotonin reuptake inhibitors (sris) are a first-line treatment for obsessive-compulsive disorder (ocd). |
2016-05-06 |
2023-08-13 |
Not clear |
| Je-Yeon Yun, Joon Hwan Jang, Sung Nyun Kim, Wi Hoon Jung, Jun Soo Kwo. Neural Correlates of Response to Pharmacotherapy in Obsessive-Compulsive Disorder: Individualized Cortical Morphology-Based Structural Covariance. Progress in neuro-psychopharmacology & biological psychiatry. vol 63. 2016-04-08. PMID:26116795. |
primary pharmacotherapy regimen for obsessive-compulsive disorder (ocd) named serotonin reuptake inhibitors (sris) does not attain sufficient symptom improvement in 40-60% of ocd. |
2016-04-08 |
2023-08-13 |
human |
| M Anupama, K H Gangadhar, Vandana B Shetty, P Bhadja Di. Transvestism as a Symptom: A Case Series. Indian journal of psychological medicine. vol 38. issue 1. 2016-03-25. PMID:27011411. |
second case had co-morbid obsessive-compulsive disorder (ocd) and had good response to selective serotonin reuptake inhibitor (ssri). |
2016-03-25 |
2023-08-13 |
Not clear |
| Mujgan Cengiz, Saide Nur Okutan, Burcu Bayoglu, Ayse Sakalli Kani, Reha Bayar, Nese Kocabasogl. Genetic Polymorphism of the Serotonin Transporter Gene, SLC6A4 rs16965628, Is Associated with Obsessive Compulsive Disorder. Genetic testing and molecular biomarkers. vol 19. issue 5. 2016-03-24. PMID:25751280. |
genetic polymorphism of the serotonin transporter gene, slc6a4 rs16965628, is associated with obsessive compulsive disorder. |
2016-03-24 |
2023-08-13 |
human |
| J Zohar, Y Sasso. Obsessive compulsive disorder: Opportunities within and beyond the serotonergic domain. Acta neuropsychiatrica. vol 9. issue 2. 2016-03-14. PMID:26972134. |
abnormality of the serotonin (5-hydroxytryptamine - 5-ht) system and particularly hypersensitivity of postsynaptic 5-ht receptors remained the leading hypothesis for the underlying pathophysiology of obsessive compulsive disorder (ocd) during the 1980s. |
2016-03-14 |
2023-08-13 |
Not clear |
| Joseph F McGuire, John Piacentini, Adam B Lewin, Erin A Brennan, Tanya K Murphy, Eric A Storc. A META-ANALYSIS OF COGNITIVE BEHAVIOR THERAPY AND MEDICATION FOR CHILD OBSESSIVE-COMPULSIVE DISORDER: MODERATORS OF TREATMENT EFFICACY, RESPONSE, AND REMISSION. Depression and anxiety. vol 32. issue 8. 2016-03-11. PMID:26130211. |
individual randomized controlled trials (rcts) have demonstrated the efficacy of cognitive behavioral therapy (cbt) and serotonin reuptake inhibitors (sris) for the treatment of youth with obsessive-compulsive disorder (ocd). |
2016-03-11 |
2023-08-13 |
Not clear |
| Giulio Perugi, Giuseppe Quaranta, Nunzio Bucc. The use of agomelatine in OCD: effects on the motivational aspects and dysregulated circadian rhythms. Expert opinion on investigational drugs. vol 24. issue 5. 2016-01-01. PMID:25727766. |
a considerable proportion of subjects with obsessive-compulsive disorder (ocd) have shown resistance or an incomplete response to the standard first-line treatment of serotonin reuptake inhibitors. |
2016-01-01 |
2023-08-13 |
human |
| Vlasios Brakoulia. Managing obsessive compulsive disorder. Australian prescriber. vol 38. issue 4. 2015-12-09. PMID:26648639. |
psychological interventions and selective serotonin reuptake inhibitors are first-line treatments for obsessive compulsive disorder. |
2015-12-09 |
2023-08-13 |
Not clear |